Table 1.
The course of differential leukocyte counts and their ratios during the liver phase in the subjects who develop malaria
| Leukocytes × 109/L | Neutrophils × 109/L | Lymphocytes × 109/L | Monocytes × 109/L | NLCR | MLCR | NMCR | |
|---|---|---|---|---|---|---|---|
| CHMI-a (n = 15) | |||||||
| Baseline | 5.8 (5.3–6.5) | 3.1 (2.9–3.3) | 1.9 (1.9–2.3) | 0.51 (0.48–0.58) | 1.6 (1.4–1.7) | Baseline | 5.8 (5.3–6.5) |
| Day 5 | 6.8 (6.1–7.3) | 3.6 (2.9–4.0) | 2.3 (2.0–2.5) | 0.55 (0.46–0.63) | 1.6 (1.4–1.8) | Day 5 | 6.8 (6.1–7.3) |
| Day 6 | 6.9 (5.8–7.6) | 3.2 (2.7–4.1) | 2.4 (1.9–2.7) | 0.55 (0.49–0.58) | 1.3 (1.1–1.9) | Day 6 | 6.9 (5.8–7.6) |
| p value | 0.105 | 0.721 | 0.140 | 0.208 | 0.623 | p value | 0.105 |
| CHMI-b (n = 20) | |||||||
| Baseline | 5.1 (4.9–6.1) | 2.8 (2.5–3.1) | 1.6 (1.5–2.0) | 0.48 (0.35–0.60) | 1.8 (1.1–2.0) | 0.3 (0.2–0.3) | 5.8 (4.7–8.3) |
| Day 5 | 5.7 (5.4–7.2) | 3.1 (2.2–3.6) | 2.0 (1.7–2.5) | 0.49 (0.43–0.60) | 1.3 (1.0–2.1) | 0.2 (0.2–0.3) | 5.9 (4.8–7.2) |
| Day 6 | 6.0 (5.3–6.9) | 3.0 (2.4–3.8) | 2.2 (1.9–2.4) | 0.53 (0.46–0.65) | 1.4 (1.1–1.8) | 0.2 (0.2–0.3) | 5.3 (4.6–7.1) |
| p value | 0.051 | 0.195 | 0.004 | 0.012 | 0.165 | 0.196 | 0.848 |
| Combined (n = 35) | |||||||
| Baseline | 5.5 (5.0–6.2) | 2.9 (2.6–3.2) | 1.9 (1.6–2.2) | 0.50 (0.38–0.60) | 1.7 (1.3–2.0) | 0.3 (0.2–0.3) | 6.1 (4.8–8.4) |
| Day 5 | 6.1 (5.5–7.2) | 3.3 (2.5–3.7) | 2.2 (1.8–2.5) | 0.50 (0.43–0.54) | 1.5 (1.1–1.9) | 0.2 (0.2–0.3) | 6.1 (4.9–8.1) |
| Day 6 | 6.1 (5.5–7.0) | 3.0 (2.6–3.9) | 2.2 (1.9–2.6) | 0.54 (0.47–0.62) | 1.4 (1.1–1.8) | 0.2 (0.2–0.3) | 5.7 (4.8–7.2) |
| p value | 0.005 | 0.413 | 0.001 | 0.038 | 0.121 | 0.368 | 0.971 |
The data of CHMI-a and CHMI-b are shown separately and combined
Data in this table are not normally distributed and shown as median (interquartile range). p values in this table were derived from Friedman tests